LAX.SH
APOLLO HOSPITALS ENTER. L·HOSPITALS 62.15·Healthcare Services Companies
Price
8,176.5
-1.17%52W Range
Market Cap
₹1,17,565.52 Cr
Traded: ₹855.07 Cr (0.73%) 0.0x
Free Float: ₹7,888.65 Cr (10.84% of FF traded)
Volume · 60D trend
10.42 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Held by ETFs
69 ETFs hold apollohosp · sorted by weight
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | +11.0% | +14.0% | +15.0% | -- | -- | Accelerating |
| Sales | +16.0% | +14.0% | +14.0% | -- | +15.0% | Stable |
| Profit | +16.0% | +34.0% | +18.0% | -- | +39.0% | Stable |
| Return | +19.0% | +22.0% | +20.0% | +24.0% | -- | Stable |
Quarterly Results
Mar 2026
20 MayDec 2025
10 FebSep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Shareholding Pattern
LAX.SH
Exchange Filings
50as per annexure enclosed
As per annexure enclosed - Publication of advertisement - NCLT convened meetings
as per annexure enclosed
as per annexure enclosed
Notice convening meeting of unsecured creditors of the Company pursuant to the orders of National Company Law Tribunal, chennai
As per annexure enclosed
As per annexure enclosed
As per annexure enclosed
as per annexure enclosed
as per annexure enclosed
As per annexure enclosed
As per annexure enclosed
as per annexure enclosed
as per annexure enclosed
as per annexure enclosed
as per annexure enclosed
As per annexure enclosed
As per annexure enclosed
Update
Apollo Hospitals Enterprise Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve As per annexure enclosed
Update - as per annexure enclosed
As per annexure enclosed
as per annexure enclosed
As per annexure enclosed
Certificate under Regulation 74(5) for the period ended 31st March 2026 enclosed
As per annexure enclosed
As per annexure enclosed
As per annexure enclosed
As per annexure enclosed
As per annexure enclosed
as per annexure enclosed
as per annexure enclosed
as per annexure enclosed
As per annexure enclosed
As per annexure enclosed
As per annexure enclosed
As per annexure enclosed
As per annexure enclosed
as per annexure enclosed
as per annexure enclosed
Apollo Hospitals Enterprise Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve As per annexure enclosed
As per annexure enclosed
As per annexure enclosed
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Schroder Investment Management (Singapore) ....
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Schroder Investment Management (Singapore) Ltd & Others
As per annexure enclosed
Apollo Hospitals Enterprise Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve As per annexure enclosed
Certificate under Regulation 74(5) for the period ended 31st December 2025 enclosed
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Karthik Anand
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Harshad Reddy
Annual Reports
15Credit Ratings
6Concalls
42Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025Jun 2025
30 Jun 2025May 2025
31 May 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024May 2024
31 May 2024Apr 2024
30 Apr 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022May 2022
31 May 2022Nov 2021
30 Nov 2021Aug 2021
31 Aug 2021Jun 2021
30 Jun 2021Jun 2021
30 Jun 2021Jun 2021
30 Jun 2021Nov 2020
30 Nov 2020Sep 2020
30 Sept 2020Jun 2020
30 Jun 2020Feb 2020
29 Feb 2020Nov 2019
30 Nov 2019Aug 2019
31 Aug 2019May 2019
31 May 2019Feb 2019
28 Feb 2019Nov 2018
30 Nov 2018Aug 2018
31 Aug 2018May 2018
31 May 2018Feb 2018
28 Feb 2018Nov 2017
30 Nov 2017Aug 2017
31 Aug 2017Apr 2017
30 Apr 2017Nov 2016
30 Nov 2016Feb 2016
29 Feb 2016Nov 2015
30 Nov 2015Detailed Financials
Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6,606 | 6,477 | 6,304 | 5,842 | 5,592 | 5,527 | 5,589 | 5,086 | 4,944 | 4,851 | 4,847 | 4,418 | 4,302 | 4,264 | 4,251 |
| Expenses | 5,594 | 5,512 | 5,362 | 4,990 | 4,822 | 4,765 | 4,774 | 4,410 | 4,303 | 4,237 | 4,219 | 3,909 | 3,814 | 3,780 | 3,699 |
| Operating Profit | 1,011 | 965 | 941 | 852 | 770 | 762 | 816 | 675 | 640 | 614 | 628 | 509 | 488 | 484 | 552 |
| OPM % | 15.0% | 15.0% | 15.0% | 15.0% | 14.0% | 14.0% | 15.0% | 13.0% | 13.0% | 13.0% | 13.0% | 12.0% | 11.0% | 11.0% | 13.0% |
| Other Income | 54 | 48 | 61 | 54 | 72 | 69 | 44 | 49 | 37 | 29 | 26 | 34 | 20 | 35 | 23 |
| Interest | 119 | 113 | 110 | 108 | 115 | 110 | 118 | 116 | 119 | 113 | 111 | 106 | 95 | 100 | 93 |
| Depreciation | 224 | 219 | 218 | 215 | 211 | 185 | 184 | 177 | 190 | 167 | 163 | 167 | 159 | 153 | 155 |
| Profit Before Tax | 722 | 682 | 675 | 583 | 516 | 536 | 557 | 430 | 368 | 363 | 379 | 270 | 254 | 266 | 327 |
| Tax % | 24.0% | 24.0% | 27.0% | 24.0% | 20.0% | 29.0% | 29.0% | 27.0% | 30.0% | 30.0% | 34.0% | 36.0% | 43.0% | 39.0% | 35.0% |
| Net Profit | 551 | 516 | 494 | 441 | 414 | 379 | 396 | 316 | 258 | 254 | 249 | 173 | 146 | 162 | 213 |
| Exceptional Items | 0 | -19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
| EPS (Rs) | 36.8 | 34.9 | 33.2 | 30.1 | 27.1 | 25.9 | 26.3 | 21.2 | 17.6 | 17.1 | 16.2 | 11.6 | 10.1 | 10.7 | 14.2 |
| Sales Growth (YoY) | 18.1% | 17.2% | 12.8% | 14.9% | 13.1% | 13.9% | 15.3% | 15.1% | 14.9% | 13.8% | 14.0% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 2.0% | 2.7% | 7.9% | 4.5% | 1.2% | -1.1% | 9.9% | 2.9% | 1.9% | 0.1% | 9.7% | 2.7% | 0.9% | 0.3% | -- |
| OP Growth (YoY) | 31.3% | 26.6% | 15.3% | 26.2% | 20.3% | 24.1% | 29.9% | 32.6% | 31.1% | 26.9% | 13.8% | -- | -- | -- | -- |
| OP Growth (QoQ) | 4.8% | 2.6% | 10.4% | 10.6% | 1.0% | -6.6% | 20.9% | 5.5% | 4.2% | -2.2% | 23.4% | 4.3% | 0.8% | -12.3% | -- |
| Profit Growth (YoY) | 36.0% | 39.0% | 26.0% | 42.0% | 54.0% | 52.0% | 63.0% | 83.0% | 76.0% | 60.0% | 14.0% | -47.0% | 60.0% | -33.0% | -18.0% |
| EPS Growth (YoY) | 35.8% | 34.9% | 26.0% | 41.8% | 53.5% | 51.8% | 62.6% | 83.2% | 75.6% | 59.7% | 14.2% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 5.4% | 5.2% | 10.3% | 11.1% | 4.7% | -1.7% | 24.1% | 20.3% | 3.5% | 5.3% | 39.8% | 15.3% | -5.9% | -24.7% | -- |
| OP Margin | 15.3% | 14.9% | 14.9% | 14.6% | 13.8% | 13.8% | 14.6% | 13.3% | 12.9% | 12.7% | 13.0% | 11.5% | 11.3% | 11.3% | 13.0% |
| Net Margin | 8.3% | 8.0% | 7.8% | 7.5% | 7.4% | 6.9% | 7.1% | 6.2% | 5.2% | 5.2% | 5.1% | 3.9% | 3.4% | 3.8% | 5.0% |
| Material Cost % | 52.0% | 52.0% | 51.0% | 52.0% | 52.0% | 52.0% | 51.0% | 52.0% | 51.0% | 52.0% | 51.0% | 51.0% | 52.0% | 52.0% | 51.0% |
| Employee Cost % | 12.0% | 12.0% | 12.0% | 12.0% | 13.0% | 12.0% | 13.0% | 13.0% | 13.0% | 13.0% | 13.0% | 13.0% | 14.0% | 13.0% | 13.0% |
| P/S | 4.66 | 4.59 | 4.83 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 60.55 | 61.74 | 67.26 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 12.40 | 12.24 | 12.37 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |